VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 94 filers reported holding VBI VACCINES INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $30 | +50.0% | 98,337 | +89.9% | 0.00% | – |
| Q4 2022 | $20 | -99.7% | 51,771 | +533.3% | 0.00% | – |
| Q3 2022 | $6,000 | -25.0% | 8,175 | -15.5% | 0.00% | – |
| Q2 2022 | $8,000 | -97.2% | 9,677 | -88.6% | 0.00% | – |
| Q2 2021 | $285,000 | -40.0% | 85,170 | -44.2% | 0.00% | – |
| Q1 2021 | $475,000 | +165.4% | 152,706 | +135.0% | 0.00% | – |
| Q4 2020 | $179,000 | – | 64,976 | +118038.2% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 55 | -99.9% | 0.00% | – |
| Q3 2019 | $19,000 | -17.4% | 41,363 | +517.2% | 0.00% | – |
| Q1 2018 | $23,000 | -76.5% | 6,702 | -70.9% | 0.00% | – |
| Q4 2017 | $98,000 | +4800.0% | 23,038 | +4489.2% | 0.00% | – |
| Q3 2017 | $2,000 | -92.0% | 502 | -91.2% | 0.00% | – |
| Q2 2017 | $25,000 | – | 5,717 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |